2735. Treatment patterns and clinical outcomes of acyclovir resistant and refractory human herpes simplex virus infection after allogeneic hematopoietic cell transplantation

BACKGROUND: Treatment options for mucocutaneous herpes simplex virus infections (HSV) refractory or resistant (r/r) to acyclovir (ACV) are limited. High-dose ACV continuous infusion, foscarnet (FCN), cidofovir (CDV), and/or topical agents have been used. We report treatment patterns and outcomes of...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yeon Joo, Li, Yuxuan, Han, Gyuri, Shah, Gunjan, Tamari, Roni, Perales, Miguel, Papanicolaou, Genovefa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677066/
http://dx.doi.org/10.1093/ofid/ofad500.2346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677066/
http://dx.doi.org/10.1093/ofid/ofad500.2346

Ejemplares similares